Villoglandular adenocarcinoma of the uterine cervix: a systematic review and meta-analysis

[1] Smith HO(2000)The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States–a 24-year population-based study Gynecol Oncol 78 97-105

[2] Tiffany MF(2005)Cervical cancer in the Netherlands 1989–1998: decrease of squamous cell carcinoma in older women, increase of adenocarcinoma in younger women Int J Cancer 113 1005-1009

[3] Qualls CR(1989)Villoglandular papillary adenocarcinoma of the uterine cervix. A clinicopathologic analysis of 13 cases Cancer 63 1773-1779

[4] Key CR(2019)International Endocervical Adenocarcinoma Criteria and Classification (IECC): correlation with adverse clinicopathological features and patient outcome J Clin Pathol 72 347-353

[5] Bulk S(2014)Prognostic factors influencing decisions about surgical treatment of villoglandular adenocarcinoma of the uterine cervix Int J Gynecol Cancer 24 1299-1305

[6] Visser O(2018)Villoglandular adenocarcinoma of cervix: pathologic features, clinical management, and outcome Cancer Manag Res 10 3955-3961

[7] Rozendaal L(2009)Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement BMJ 339 b2535-194

[8] Verheijen RH(2006)Villoglandular adenocarcinoma of the cervix: clarity is needed on the histological definition for this difficult diagnosis Gynecol Oncol 100 192-189

[9] Meijer CJ(1999)Villoglandular papillary adenocarcinoma of the cervix. Beware of a wolf in sheep's clothing Eur J Obstet Gynecol Reprod Biol. 87 183-358

[10] Young RH(2009)Villoglandular papillary adenocarcinoma of the uterine cervix: a diagnostic challenge Acta Obstet Gynecol Scand 88 355-888

[1] Smith HO(2000)The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States–a 24-year population-based study Gynecol Oncol 78 97-105

[2] Tiffany MF(2005)Cervical cancer in the Netherlands 1989–1998: decrease of squamous cell carcinoma in older women, increase of adenocarcinoma in younger women Int J Cancer 113 1005-1009

[3] Qualls CR(1989)Villoglandular papillary adenocarcinoma of the uterine cervix. A clinicopathologic analysis of 13 cases Cancer 63 1773-1779

[4] Key CR(2019)International Endocervical Adenocarcinoma Criteria and Classification (IECC): correlation with adverse clinicopathological features and patient outcome J Clin Pathol 72 347-353

[5] Bulk S(2014)Prognostic factors influencing decisions about surgical treatment of villoglandular adenocarcinoma of the uterine cervix Int J Gynecol Cancer 24 1299-1305

[6] Visser O(2018)Villoglandular adenocarcinoma of cervix: pathologic features, clinical management, and outcome Cancer Manag Res 10 3955-3961

[7] Rozendaal L(2009)Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement BMJ 339 b2535-194

[8] Verheijen RH(2006)Villoglandular adenocarcinoma of the cervix: clarity is needed on the histological definition for this difficult diagnosis Gynecol Oncol 100 192-189

[9] Meijer CJ(1999)Villoglandular papillary adenocarcinoma of the cervix. Beware of a wolf in sheep's clothing Eur J Obstet Gynecol Reprod Biol. 87 183-358

[10] Young RH(2009)Villoglandular papillary adenocarcinoma of the uterine cervix: a diagnostic challenge Acta Obstet Gynecol Scand 88 355-888